Engineered Yeast to Help Boost Drug SupplyMay 31, 2023
Synthetic biology can be used to make more drugs or raw materials for the transformation of the pharmaceutical supply chains. This is according to Dr. Christian Smolke, CEO and co-founder of Antheia—science and technology company developing next-generation plant-inspired medicines.
Dr. Smolke explained that this transformation could be achieved through the use of engineered yeast that can yield active pharmaceutical ingredients (APIs). This breakthrough could lead to the reduction of drug shortages through less dependence on ingredients derived from nature. She said that sourcing active ingredients from nature is very inefficient and time-consuming. To address this problem, Antheia developed engineered yeast to produce APIs. The yeast is grown in a fermenter, thus, can make a batch of purified product in less time.
To date, Antheia has approximately 70 active ingredients in the pipeline, and the first batch will be produced in full-scale this 2023.
Know more in Genetic Engineering and Biotechnology News.
You might also like:
- GM Yeast Found to Effectively Control Tsetse Flies
- Scientists Clone SARS-CoV-2 Genome Using Quick Yeast-Based Method
- EFSA Evaluates Risk Assessment Guidelines for Synthetic Biology GM Plant Developments
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
News from Around the World
- Save the Date: APEC High-Level Policy Dialogue on Agricultural Biotechnology Activities
- Groundbreaking Images of Root Chemicals Reveal New Insights on Plant Growth
- KAUST Researchers Clone Wheat Disease Resistance Genes
- ISAAA Inc. to Hold ASCA6 on September 11-15 in Indonesia
- Roslin Institute and Oxitec Collaborate to Curb Major Cattle Pest
- Engineered Yeast to Help Boost Drug Supply
Read the latest:
- Biotech Updates (September 20, 2023)
- Gene Editing Supplement (September 13, 2023)
- Gene Drive Supplement (February 22, 2023)
Subscribe to BU: